LivaNova PLC
LIVN
Pozycja w akcjach
#3734
LivaNova PLC is a global medical technology company dedicated to developing,... LivaNova PLC is a global medical technology company dedicated to developing, manufacturing, and marketing a variety of therapeutic solutions. The company operates through three key segments. Its Cardiopulmonary division provides essential products for heart-lung procedures, such as oxygenators, heart-lung machines, and various perfusion systems. The Neuromodulation segment is known for its VNS Therapy System, an implantable device that delivers vagus nerve stimulation to treat drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. This segment is also advancing the VITARIA System, which employs VNS for heart failure, through clinical development. The Advanced Circulatory Support segment offers temporary life support solutions, including both cardiopulmonary and respiratory support technologies. LivaNova serves a wide range of medical professionals, including perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals and healthcare providers. The company's products are distributed globally through both its direct sales force and independent distributors. Additionally, LivaNova has a research collaboration with Verily aimed at discovering clinical biomarkers for depression. Founded in 1987, the company is headquartered in London, United Kingdom.
Cena akcji
$80.82
Kapitalizacja rynkowa
$4.44B
Zmiana (1 dzień)
3.03%
Zmiana (1 rok)
47.35%
Kraj
GB
Handel LivaNova PLC (LIVN)
Kategoria
Healthcare
Historia ceny akcji dla LivaNova PLC (LIVN)
Najwyższa cena zamknięcia: $77.02 dnia 2026-10-01
Najniższa cena zamknięcia: $65.54 dnia 2015-10-01
Najniższa cena zamknięcia: $65.54 dnia 2015-10-01
Historia cen akcji firmy LivaNova PLC od 2015 do 2026
Roczna wydajność ceny akcji
| Rok | Wydajność |
|---|---|
| 2026 (TTM) | 10.23% |
| 2025 | 28.07% |
| 2024 | 0.72% |
| 2023 | -10.64% |
| 2022 | -34.07% |
| 2021 | 32.23% |
| 2020 | -19.53% |
| 2019 | -16.15% |
| 2018 | 13.93% |
| 2017 | 79.34% |
| 2016 | -22.00% |
| 2015 | 0.00% |
Cena akcji podobnych firm lub konkurencji
| Firma | Cena akcji | Zmiana 1r% | Kraj |
|---|---|---|---|
| $102.59 | -19.82% |
US
|
|
| $95.92 | 0.02% |
IE
|
|
| $305.16 | -21.42% |
US
|
|
| $45.72 | -55.97% |
US
|
|
| $47.05 | -17.88% |
DE
|
